Take a closer look at VUMERITY

More people have started VUMERITY than any other brand-name pill for relapsing MS in the US since December 2020.* Could it be right for you? Take a look at the video below to find out more. 

Get to know VUMERITY

Watch to learn more about VUMERITY. Then, start a conversation with your healthcare provider to see if this treatment option could be a good fit.

*Based on the number of new MS prescriptions for the months December 2020 through August 2022 per IQVIA NPA New to Brand, Patient Insights® monthly NBRx.


[Music cues up]


FEMALE VOICEOVER: Relapsing MS won’t tell me who to be.

Legal disclaimer: Actor portrayals.

SONG: Don’t tell me who to be…
I’m still me…
I’m still me…
I’m still me…
I’m still me…

[Music dips]

Legal disclaimer: Once it’s processed in the body, VUMERITY takes the same active form as dimethyl fumarate (DMF). The information from the clinical trials is DMF data.

FEMALE VOICEOVER: VUMERITY is a pill for adults with relapsing multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Legal disclaimer: VUMERITY is a prescription medicine used to treat people with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. It is not known if VUMERITY is safe and effective in children

FEMALE VOICEOVER: VUMERITY reduces relapses, which is a treatment goal in relapsing MS.

Legal disclaimer: In two studies vs placebo, DMF reduced the number of relapses by 53% (0.172 vs 0.364) and 44% (0.224 vs 0.401), respectively. DMF also reduced the risk of relapse by 49% (27% of people on DMF had a relapse vs 46% on placebo) and 34% (29% on DMF had a relapse vs 41% on placebo), respectively.

FEMALE VOICEOVER: VUMERITY also slows the development of brain lesions that are shown on MRIs.

Legal disclaimer: Study 1: Compared with placebo, DMF reduced the number of Gd+ lesions by 90%, new or newly enlarging T2 lesions by 85%, and new T1 lesions by 72%. Study 2: DMF reduced the number of new or newly enlarging lesions by 74%, 71%, and 57%, respectively. The link between brain lesions and the progression of relapsing MS has not been confirmed.

FEMALE VOICEOVER: And, VUMERITY may delay disability progression.

Legal disclaimer: Study 1: 16% of people on DMF had disability progression vs 27% on placebo. Study 2: 13% of people on DMF had disability progression vs 17% on placebo. There was no statistically significant effect on disability progression in Study 2.

FEMALE VOICEOVER: Since VUMERITY is a pill, you can take it from the comfort of home, or wherever your day takes you.



FEMALE VOICEOVER: Do not take VUMERITY if you are allergic to diroximel fumarate, dimethyl fumarate, or any of the ingredients in VUMERITY, or are taking dimethyl fumarate.

Legal disclaimer: Allergic reaction could include welts, hives, swelling of the face, lips, mouth or tongue, or difficulty breathing.

FEMALE VOICEOVER: VUMERITY may cause serious side effects, including allergic reactions, PML, a rare, potentially fatal brain infection, herpes zoster infections or shingles, including central nervous system infections, other serious infections, decreases in your white blood cell count, and liver problems.

Legal disclaimer: PML (progressive multifocal leukoencephalopathy) is a rare brain infection that usually leads to death or severe disability.

FEMALE VOICEOVER: Your healthcare provider should check your white blood cell count and liver function before and during treatment.


FEMALE VOICEOVER: Tell your healthcare provider about any infections or other medical conditions. The most common side effects are flushing and stomach problems.

[Music up]

Legal disclaimer: These can happen especially at the start of treatment and may decrease over time.

SONG: I’m still me…
I’m still me…
I’m still me…


Legal disclaimer: If you take too much VUMERITY, call your healthcare provider or go to the nearest ER right away.


Legal disclaimer: Tell your healthcare provider if you’re pregnant, breastfeeding, or planning to get pregnant or breastfeed.

FEMALE VOICEOVER: Ask your healthcare provider if VUMERITY is right for you.


Legal disclaimer:
*Eligibility and limitations apply.
  © 2021 Biogen. All rights reserved. 08/21 VUM-US-0771

[ISI present in video and available below.]


All Videos

Relapsing MS won't tell me
who to be

Meet Nichole and Giseli, two of our ambassadors, and hear how they decided on VUMERITY.

Interested in sharing your story?

If you currently take VUMERITY, we’d love to hear from you! Email us at, or call 1-844-706-5726 to tell us more about your experience with VUMERITY.

“Every day I have a choice. I can say, ‘Why me?’ or I can say, ‘Why not me?’ I choose to say, ‘Why not me? ’”

– Karen J., VUMERITY Ambassador

geometric shape